Clinical outcomes and resource utilization after surgical resection with curative intent among patients with non‐small cell lung cancer treated with adjuvant therapies in a community oncology setting: A real‐world retrospective observational study-Reference-Cited by-同舟云学术

Clinical outcomes and resource utilization after surgical resection with curative intent among patients with non‐small cell lung cancer treated with adjuvant therapies in a community oncology setting: A real‐world retrospective observational study

Published:2021-05-24 Issue:14 Volume:12 Page:2055-2064
ISSN:1759-7706
Container-title:Thoracic Cancer
language:en
Short-container-title:Thorac Cancer

Author:

Cai Beilei¹,Fulcher Nicole²,Boyd Marley²,Spira Alexander³

Affiliation:

1. Novartis Pharmaceuticals East Hanover New Jersey USA

2. Ontada The Woodlands Texas USA

3. Virginia Cancer Specialists/The US Oncology Network Fairfax Virginia USA

Funder

Novartis

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/1759-7714.14007

Reference22 articles.

1. Cancer statistics, 2020

2. SEER Cancer Statistics Review 1975‐2017 National Cancer Institute Bethesda MD [Internet]. [updated April 15 2020; cited September 17 2020].https://seer.cancer.gov/csr/1975_2017/

3. Recurrence after surgery in patients with NSCLC;Uramoto H;Transl Lung Cancer Res,2014

4. Postoperative Adjuvant Systemic Therapy in Completely Resected Non–Small-Cell Lung Cancer: A Systematic Review

5. National Comprehensive Cancer Network.NCCN Clinical Practice Guidelines in Oncology: Non‐Small Cell Lung Cancer V1 (2020) [Internet]. [updated 2 October 2019

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting hyaluronan metabolism-related molecules associated with resistant tumor-initiating cells potentiates chemotherapy efficacy in lung cancer;Scientific Reports;2024-07-22

2. A retrospective analysis of treatment patterns, overall survival, and real-world disease-free survival in early-stage non-small cell lung cancer following complete resection;BMC Pulmonary Medicine;2024-07-10

3. Event-free survival as a predictor of overall survival and recurrence burden of patients with non–small cell lung cancer receiving neoadjuvant therapy;The Journal of Thoracic and Cardiovascular Surgery;2023-12

4. Economic burden of early-stage non-small-cell lung cancer: an assessment of healthcare resource utilization and medical costs;Journal of Comparative Effectiveness Research;2023-11

5. Neoadjuvant Targeted Therapy in Resectable NSCLC: Current and Future Perspectives;Journal of Thoracic Oncology;2023-11